Genetic syndromes and their associations with congenital heart disease

Freeman, 1998, Population-based study of congenital heart defects in down syndrome, Am J Med Genet, 80, 213, 10.1002/(SICI)1096-8628(19981116)80:3<213::AID-AJMG6>3.0.CO;2-8 Pritchard, 1999, The, "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in down syndrome, J Neural Transm Suppl, 57, 293 Barlow, 2001, Down syndrome congenital heart disease: a narrowed region and a candidate gene, Genet Med, 3, 91, 10.1097/00125817-200103000-00002 Cescon, 2015, Collagen VI at a glance, J Cell Sci, 128, 3525 Davies, 1993, Polymorphisms and linkage disequilibrium in the COL6A1 and COL6A2 gene cluster: novel DNA polymorphisms in the region of a candidate gene for congenital heart defects in Down's syndrome, Hum Genet, 90, 521, 10.1007/BF00217452 Gittenberger-de Groot, 2003, Collagen type VI expression during cardiac development and in human fetuses with trisomy 21, Anat Rec A Discov Mol Cell Evol Biol, 275, 1109, 10.1002/ar.a.10126 Gao, 2013, Understanding the role of Tbx1 as a candidate gene for 22q11.2 deletion syndrome, Curr Allergy Asthma Rep, 13, 613, 10.1007/s11882-013-0384-6 Goldmuntz, 2020, 22q11.2 deletion syndrome and congenital heart disease, Am J Med Genet C Semin Med Genet, 184, 64, 10.1002/ajmg.c.31774 Baldini, 2005, Dissecting contiguous gene defects: TBX1, Curr Opin Genet Dev, 15, 279, 10.1016/j.gde.2005.03.001 Merscher, 2001, TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome, Cell, 104, 619, 10.1016/S0092-8674(01)00247-1 Xu, 2004, Tbx1 has a dual role in the morphogenesis of the cardiac outflow tract, Development, 131, 3217, 10.1242/dev.01174 Hu, 2004, Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors, Development, 131, 5491, 10.1242/dev.01399 Twite, 2019, Williams syndrome, Paediatr Anaesth, 29, 483, 10.1111/pan.13620 Kozel, 2021, Williams syndrome, Nat Rev Dis Primers, 7, 42, 10.1038/s41572-021-00276-z Li, 1998, Novel arterial pathology in mice and humans hemizygous for elastin, J Clin Invest, 102, 1783, 10.1172/JCI4487 O'Connor, 1985, Supravalvular aortic stenosis. Clinical and pathologic observations in six patients, Arch Pathol Lab Med, 109, 179 Perou, 1961, Congenital supravalvular aortic stenosis. A morphological study with attempt at classification, Arch Pathol, 71, 453 Parrish, 2020, Whole exome sequencing in patients with Williams-Beuren syndrome followed by disease modeling in mice points to four novel pathways that may modify stenosis risk, Hum Mol Genet, 29, 2035, 10.1093/hmg/ddaa093 Kimura, 2019, Integrative network analysis reveals biological pathways associated with Williams syndrome, J Child Psychol Psychiatry, 60, 585, 10.1111/jcpp.12999 Sharland, 1992, A clinical study of Noonan syndrome, Arch Dis Child, 67, 178, 10.1136/adc.67.2.178 Romano, 2010, Noonan syndrome: clinical features, diagnosis, and management guidelines, Pediatrics, 126, 746, 10.1542/peds.2009-3207 Pandit, 2007, Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy, Nat Genet, 39, 1007, 10.1038/ng2073 Sarkozy, 2003, Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes, J Med Genet, 40, 704, 10.1136/jmg.40.9.704 Allen, 2022 Chen, 2019, Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort, Orphanet J Rare Dis, 14, 29, 10.1186/s13023-019-1010-z Chen, 2000, Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis, Nat Genet, 24, 296, 10.1038/73528 Gallo, 2019, ERK: a key player in the pathophysiology of cardiac hypertrophy, Int J Mol Sci, 20, 10.3390/ijms20092164 Sala, 2012, Signaling to cardiac hypertrophy: insights from human and mouse RASopathies, Mol Med, 18, 938, 10.2119/molmed.2011.00512 Carrier, 2021, Targeting the population for gene therapy with MYBPC3, J Mol Cell Cardiol, 150, 101, 10.1016/j.yjmcc.2020.10.003 Kieserman, 2019, Current landscape of heart failure gene therapy, J Am Heart Assoc, 8, 10.1161/JAHA.119.012239 Cao, 2021, Gene therapy for cardiovascular disease: basic research and clinical prospects, Front Cardiovasc Med, 8, 10.3389/fcvm.2021.760140 Bezzerides, 2020, Gene therapy for inherited arrhythmias, Cardiovasc Res, 116, 1635, 10.1093/cvr/cvaa107 Gelb, 2015, Cardiomyopathies in Noonan syndrome and the other RASopathies, Prog Pediatr Cardiol, 39, 13, 10.1016/j.ppedcard.2015.01.002